Does BIMEKIZUMAB-BKZX Cause Therapy interrupted? 252 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 252 reports of Therapy interrupted have been filed in association with BIMEKIZUMAB-BKZX. This represents 4.7% of all adverse event reports for BIMEKIZUMAB-BKZX.
252
Reports of Therapy interrupted with BIMEKIZUMAB-BKZX
4.7%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
15
Hospitalizations
How Dangerous Is Therapy interrupted From BIMEKIZUMAB-BKZX?
Of the 252 reports, 15 (6.0%) required hospitalization.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 252 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Psoriasis (621)
Drug ineffective (402)
Product availability issue (364)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
Incorrect dose administered (209)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Therapy interrupted Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES